Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.2B | 3.2B | 3.1B |
Cost of revenue | 2.2B | 2.2B | 2.2B | 2.1B |
Gross profit | 1B | 993M | 993M | 1.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 738M | 738M | 724M | 781M |
Other operating expenses | — | — | — | — |
Operating income | 200M | 192M | 205M | 174M |
Non operating interest income | ||||
Income | 6M | 6M | 7M | 6M |
Expense | 35M | 35M | 34M | 32M |
Other income expense | -26M | -37M | -50M | -16M |
Pretax income | 145M | 126M | 128M | 132M |
Tax provision | 35M | 31M | 32M | 33M |
Net income | 113M | 96M | 99M | 105M |
Basic EPS | 0.9 | 0.8 | 0.8 | 0.8 |
Diluted EPS | 0.9 | 0.7 | 0.8 | 0.8 |
Basic average shares | 123.8M | 124.5M | 126.1M | 127.8M |
Diluted average shares | 124.8M | 125.6M | 127.1M | 128.6M |
EBITDA | 278M | 261M | 284M | 253M |
Net income from continuing op. | 113M | 96M | 99M | 105M |
Minority interests | -3M | -2M | 0 | -1M |
Preferred stock dividends | — | — | — | — |